Feasibility Study for Collection of HER2 Data by NCI Surveillance, Epidemiology and End Results (SEER) Program Central Cancer Registries

The clinical importance of human epidermal growth factor receptor-2 (HER2) in breast cancer is now clearly established given that expression of this tumor marker is used to guide therapy and as a prognostic indicator. Despite its now routine evaluation in breast cancer patients, population-based dat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Reichman, Marsha E., Altekruse, Sean, Li, Christopher I., Chen, Vivien W., Deapen, Dennis, Potts, Mary, Wu, Xiao-Cheng, Morrell, Donna, Hafterson, Jennifer, Phipps, Amanda I, Harlan, Linda C., Ries, Lynn G., Edwards, Brenda K.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2805457/
https://ncbi.nlm.nih.gov/pubmed/20056633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-09-0807
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares